December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision ↗
Via Benzinga
Exposures Product Safety
News headline image
Frank Elsner Launches Personal Safety Culture Pledge for Workplaces
Via 24-7 Press Release
Topics Death Product Recall
Exposures Death Legal Product Safety
News headline image
New Castle Traumatic Brain Injury Attorney Lawrence M. Kelly Explains Memory Loss After Car Accidents in Pennsylvania
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Beta Bionics BBNX Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Tickers BBNX
Exposures Product Safety
News headline image
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗
Via The Motley Fool
Topics Stocks
Tickers AMZN HIMS NVO
Exposures Product Safety US Equities
News headline image
Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers VRDN
Exposures Legal Product Safety Regulatory
News headline image
Presidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
What Should Users Know When Bulk Purchasing Plastic Bottle
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
News headline image
Agios (AGIO) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers AGIO
Exposures Financial Product Safety
News headline image
Urban Edge (UE) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers UE
Exposures Product Safety
News headline image
Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
Via PRLog
Exposures Product Safety
News headline image
Agios (AGIO) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers AGIO
Exposures Product Safety
News headline image
BXMT Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers BXMT
Exposures Financial Product Safety
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment
Via Investor Brand Network
Tickers NNVC
Exposures COVID-19 Product Safety
News headline image
Ionis (IONS) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Tickers IONS
Exposures Product Safety
News headline image
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk ↗
Via Benzinga
Exposures COVID-19 Product Safety
News headline image
PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Via Newsfile
Tickers CSE:PHRM PHRRF
Exposures Product Safety
News headline image
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗
Via The Motley Fool
Tickers ABBV HIMS LLY NVO PFE
Exposures Product Safety
News headline image
Top Wall Street Forecasters Revamp Intuitive Surgical Expectations Ahead Of Q1 Earnings ↗
Via Benzinga
Exposures Product Safety
News headline image
Non-Pharmaceutical Knee Pain Treatment With StemWave Announced, DuBois PA
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Deadline Approaching for Investors of ImmunityBio, Inc. (NASDAQ: IBRX) - Contact Kaplan Fox Before May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Deadline Approaching for Investors of ImmunityBio, Inc. (NASDAQ: IBRX) - Contact Kaplan Fox Before May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Ibogaine by David Dardashti Aligns with New Federal”Right to Try” Directives to Target the NeurologicalRoots of Childhood Trauma
Via AB Newswire
Exposures Product Safety
News headline image
Save This Psychedelic Stock Watchlist After Trump’s Latest Executive Order
Via Barchart.com
Topics Cannabis ETFs Government
Exposures Cannabis Political Product Safety
News headline image
Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here?
Via Barchart.com
Topics Government
Exposures Political Product Safety
News headline image
AMATORUS WOUND GUARD Passes all Antimicrobial Efficacy Testing
Via Get News
Tickers AAPL
Exposures Product Safety
News headline image
Here's Why Agios Pharmaceuticals Crashed 23% Today ↗
Via The Motley Fool
Tickers AGIO NVO
Exposures Product Safety
News headline image
Why Compass Pathways Stock Rocketed 40% Today ↗
Via The Motley Fool
Topics Government
Tickers CMPS MMM
Exposures Political Product Safety
News headline image
What's Pushing Moderna Stock Higher Today? ↗
Via Benzinga
Tickers MRNA
Exposures Product Safety
PsychedelicNewsBreaks –  Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Supports Executive Order Advancing Psychedelic Therapies
Via Investor Brand Network
Tickers HELP
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.